Table 1 –
Clinical, pathologic, and biochemical preoperative data of the 17 patients included for anterior partial prostatectomy
| Clinical | |
|---|---|
| Age, yr, mean (IQR) | 61 (54–66) |
| Preoperative PSA, ng/ml, median (IQR) | 9.8 (7.1–11.3) |
| Biopsies | |
| No. of cases with previous negative biopsy series, n (%) | 11 (65) |
| No. of cases with cancer at 12 systematic posterior biopsies, n (%) | 6 (35) |
| Maximum CCL at 12 systematic posterior biopsies, mm, median (IQR) | 1 (1–2) |
| Maximum CCL at targeted biopsies, mm, median (IQR) | 8 (7–9) |
| Gleason score, n | |
| 6 (3 + 3) | 8 |
| 7 (3 + 4) | 8 |
| 7 (4 + 3) | 1 |
| MRI | |
| Prostate volume, cm3, median (IQR) | 45 (37–59) |
| Cancer volume, cm3, median (IQR) | 4.15 (1.7–4.6) * |
| Tumor location, n | |
| Midline AFMS | 11 |
| Midline TZ/AFMS | 2 |
| Lateral TZ and AFMS | 3 |
| No visible lesion | 1* |
AFMS = anterior fibromuscular stroma; CCL = cancer core length; IQR = interquartile range; MRI = magnetic resonance imaging; PSA = prostate-specific antigen; RP = radical prostatectomy; TZ = transition zone.
*
MRI was not suspicious for case 4, and cancer volume could not be calculated.